Breaking News
February 18, 2018 - Parents Find Kids’ Weight Report Cards Hard to Swallow
February 18, 2018 - Does a Financial Conflict of Interest Ever Expire?
February 18, 2018 - Exercise can improve Alzheimer’s symptoms
February 18, 2018 - Scientists develop green chemistry method to improve pharmaceutical manufacturing efficiency
February 17, 2018 - ‘A Time Clock to a Tissue Clock’ for Acute Stroke Care
February 17, 2018 - Cancer Care Gets Personal | NIH News in Health
February 17, 2018 - Do more youth use or do youth use more?
February 17, 2018 - Eating faster linked to obesity
February 17, 2018 - Who’s Still Smoking? ACS Report Highlights Most Vulnerable Adults
February 17, 2018 - Study of smoking and genetics illuminates complexities of blood pressure
February 17, 2018 - Study reveals new link between bone cells and blood glucose level
February 17, 2018 - Children with reading challenges may have lower than expected binocular vision test results
February 17, 2018 - Mass Shootings Trigger Change for Emergency Medicine
February 17, 2018 - ECMO helps revive woman thought to be drowned
February 17, 2018 - Learning stress-reducing techniques may benefit people with epilepsy
February 17, 2018 - Shedding Pounds Before Weight-Loss Surgery a Smart Move
February 17, 2018 - FDA Approves New Cystic Fibrosis Drug Combo
February 17, 2018 - Augmented Reality helps surgeons to ‘see through’ tissue and reconnect blood vessels
February 17, 2018 - Emotional state affects operation of the entire brain instead of being restricted to specific regions
February 17, 2018 - Apalutamide Slows Metastasis in Prostate Cancer
February 17, 2018 - Kids’ well visits linked to lower appendicitis complications
February 17, 2018 - New NK cell-based immunotherapy effective against several types of leukemia
February 17, 2018 - Producing Super-Swelled Lyotropic Crystals for Drug Development
February 17, 2018 - Pfizer Receives Breakthrough Therapy Designation from FDA for PF-04965842, an oral JAK1 Inhibitor, for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis
February 17, 2018 - Molecular Imaging Flags Risk of AAA Rupture
February 17, 2018 - Researchers identify risk factors for sleep apnea during pregnancy
February 17, 2018 - More work required to find the right drug dosage for pediatric patients
February 17, 2018 - Factors ID’d That Predict RA Remission with Etanercept
February 17, 2018 - A handout or a hand up? How we judge others guides how we help others
February 17, 2018 - ACR receives grant to focus on projects that reduce health disparities
February 17, 2018 - Pimavanserin Might Be Safer Alternative to Ease Dementia Psychosis
February 17, 2018 - Risks of Lung Screening Seen Outweighing Benefits in Many with Smoking History
February 17, 2018 - The impact of Hurricane Harvey on pregnant moms
February 17, 2018 - Gene editing tool used to detect cancer
February 17, 2018 - Researchers detail molecular atlas of cells that form brain’s blood vessels
February 17, 2018 - TUM scientists observe formation of myelin sheaths around nerve fibers
February 17, 2018 - Worst Flu Season Yet? | Medpage Today
February 17, 2018 - Finding the root cause of bronchiolitis symptoms
February 17, 2018 - Climbing stairs reduces hypertension and strengthens muscles
February 17, 2018 - Nature paper unveils bacterial division
February 16, 2018 - Postoperative pain control following extensive pelvic exenteration
February 16, 2018 - Daré Bioscience, Inc. Enters into License and Collaboration Agreement for a Product with the Potential to Receive the First FDA Approval for Female Sexual Arousal Disorder
February 16, 2018 - Havana Embassy Staff: ‘Concussion Without Concussion’?
February 16, 2018 - Family impact of congenital Zika syndrome likely to last a lifetime
February 16, 2018 - STI Prevention Helped By Also Discussing Pot, Alcohol Use
February 16, 2018 - New method maps the dopamine system in Parkinson’s patients
February 16, 2018 - Monitoring the Environment of Aseptic Processes
February 16, 2018 - Study finds decline in number of clinical trials funded by NIH
February 16, 2018 - Scientists show connection between sugar chains and bone growth
February 16, 2018 - Researchers develop new method for producing personalized medicine
February 16, 2018 - Women exposed to cleaning products suffer decreased lung function, Study finds
February 16, 2018 - Stem cell vaccine helps protect mice against numerous cancers
February 16, 2018 - Does Your Valentine Have a Roving Eye? Watch Out
February 16, 2018 - All Your MIPS Questions Answered — Sort Of
February 16, 2018 - Mitochondria may protect brain against Parkinson’s
February 16, 2018 - Key proteins could help in controlling the risk of osteoarthritis during aging, Study finds
February 16, 2018 - New review examines effectiveness of cupping therapy in athletes
February 16, 2018 - Resolving Interfacial Protein Dynamics by STReM
February 16, 2018 - Study provides new insights on why healthy children die from flu
February 16, 2018 - Self-sampling followed by HPV testing can benefit women at risk of cervical cancer
February 16, 2018 - Biomedical engineers grow living windpipe structures from self-assembled modules
February 16, 2018 - New device could allow people with disabilities to live more independently, enhance their quality of life
February 16, 2018 - Research identifies gene variants that play key role in how ovarian cancer patients process chemotherapy
February 16, 2018 - iMedicalApps: OB Wheels App Review
February 16, 2018 - To improve self-control, call weight loss what it is: Difficult
February 16, 2018 - Cervical tumors may be vulnerable to therapies that attack cancer’s fuel supply, study shows
February 16, 2018 - Allergan Announces Positive Top Line Phase 3 Results for Ubrogepant – an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine
February 16, 2018 - Morning Break: Hello Not-So-Fresh; One Eye, 14 Worms; Foreign Accent Syndrome
February 16, 2018 - New medical advances marking the end of a long reign for ‘diet wizards’
February 16, 2018 - Researchers study how unexpected event makes people to stop an action
February 16, 2018 - Women using short-acting asthma relievers take longer to become pregnant, study shows
February 16, 2018 - Fathers maybe passing on ovarian cancer genes to their daughters
February 16, 2018 - Phonak expands its latest-generation Belong platform with Phonak Naída B, Phonak Sky B hearing aids
February 16, 2018 - FDA Approves Erleada (apalutamide) for Non-Metastatic Castration-Resistant Prostate Cancer
February 16, 2018 - Traces of caffeine and its byproducts in the blood can be indicative of Parkinson’s disease
February 16, 2018 - More Help Needed With Opioid Crisis, Senators Told
February 16, 2018 - Are women really under-represented in clinical trials?
February 16, 2018 - US-based clinical study highlights safety and effectiveness of MENTOR MemoryShape Gel Breast Implants
February 16, 2018 - Higher levels of lifestyle physical activity linked to more gray matter in older adults’ brains
February 16, 2018 - Pfizer to use BC Platforms’ technology solutions to analyze data in cardiovascular diseases
What is inflammation and how does it cause disease?

What is inflammation and how does it cause disease?

image_pdfDownload PDFimage_print
Why do cuts, bites and injuries become swollen and red? Credit: www.shutterstock.com

Inflammation has a major impact on our health and quality of life. It’s the trigger behind many chronic diseases and a growing burden affecting health care across the globe. But what is inflammation? And what causes it?

Quintessentially, inflammation is the swollen, red, sore, hot area around the rose thorn embedded in your finger, or the pain and swelling around the ankle you sprained coming down the stairs. In these situations, inflammation is very obvious and uncomfortable. But it’s doing its job to protect us by aggressively recruiting the immune system to ward off or fight infection or respond to tissue damage.

When immune cells on patrol detect a bug or a “danger” signal, they send out an array of chemicals. Some are designed to kill invading bugs while others, called cytokines, recruit other immune cells to the site. The permeability of blood vessels increases to enhance access to the site.

So the redness, swelling and pain are due to an influx of cells and fluid, as well as some unfortunate collateral damage to our local tissues in the heat of this battle.

Our finger or ankle will return to normal as the signs of inflammation wane over days or weeks. This is because inflammation is programmed to stop. Chemicals released by immune cells at the site deliberately switch the battle from an attack phase to a healing phase to return our tissues to normal after the danger has passed.

Often people will also take “anti-inflammatories”. These don’t necessarily disrupt the healing process but reduce the side effects such as pain and swelling.

So inflammation is one of our most ancient forms of defence and it works rapidly and efficiently to protect us in many situations.

What can go wrong?

The failure to turn off inflammation in chronic disease has dire, painful and debilitating consequences, as patients with rheumatoid arthritis or inflammatory bowel disease will readily agree.

In these inflammatory diseases, the normally reliable “on/off” chemical controls of inflammation are disrupted. This means inflammation continues instead of being stopped, or it is unleashed inappropriately at sites such as joints or in the gut, wreaking havoc as it damages our own tissues. Without the important “off” signals, our immune cells keep letting out damaging chemicals and killing our own cells, even in the absence of any microbial threat.

We now know inflammation is unleashed in many circumstances and in an increasing number of common, chronic diseases. Our modern society is replete with inflammation triggers. These can be found in cigarette smoke; pollutants in our air, water or food; our gut microbiomes; and in mental cues, such as stress.

As a result of our environment and lifestyles, we now live constantly with low levels of inflammatory signals “arming” our immune systems. This is a silent menace, not causing the usual overt signs of inflammation, but nevertheless complicating other disease processes that may be present.

Ageing can also reduce the stringency of our inflammation controls. Inflammation is now recognised as a significant cause or complicating factor in diabetes, obesity, cancer, depression and heart disease.

What diseases can inflammation cause?

Recent research suggests inflammation might also cause neurodegenerative diseases such as Alzheimer’s and Parkinson’s. In a large-scale genetic study that compared people with and without Alzheimer’s disease, many of the DNA changes occurred in genes associated with inflammatory pathways. This implicates inflammation as either causing or responding to the condition.

A study earlier this year made headlines by showing that reducing inflammation with a specific drug provided significant protection against recurring heart attacks and also reduced the incidence of lung cancer in smokers.

Inflammation has a complex relationship with most cancers. While early activation of inflammatory responses can help immune cells kill cancer cells, in later stages inflammation can unwittingly help cancer cells spread.

How can we treat inflammation?

While we can take steroids or anti-inflammatory medications to suppress some instances of acute inflammation (such as your sprained ankle), in chronic diseases we need to know which parts of the inflammatory pathway should be boosted or dialled down at different stages of disease. So we need to find a way to balance our immune response, rather than simply enhancing or muting it.

Research is giving more information about the normal regulatory pathways that turn inflammation on and off. This has already resulted in some very successful treatments that target specific inflammatory mediators in arthritis, bowel diseases and other conditions.

These treatments have often used antibodies to target and block inflammatory mediators (cytokines). This has been very successful at suppressing unwanted inflammation in some patients. Recently identified proteins in immune cells are now also being targeted to develop additional treatments for inflammatory bowel disease in patients who do not respond well to cytokine-targeting drugs.

Incredibly, unlocking the on/off secrets of inflammation with new research (and hopefully drugs) will be the key to controlling this underlying menace in many diseases and providing new treatments for many patients.


Explore further:
Maintaining sufficient vitamin D levels may help to prevent rheumatoid arthritis

Provided by:
The Conversation

Tagged with:

About author

Related Articles